a leader in the worldwide diabetes and obesity care market, has been witnessing stellar performance of its GLP-1 agonist, semaglutide. Apart from the oral formulation of the drug sold as Rybelsus ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

The survey of 1,078 adults, carried out by Ipsos, found 24% of people would use weight-loss jabs if they were provided for ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

It is marketed under brand names such as Ozempic, Wegovy, and Rybelsus, each approved for specific uses: Ozempic: Approved ...

and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States. Semaglutide is also used to manage type 2 diabetes. The drug suppresses appetite and promotes satiety ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...